Slates of Candidates
View the Slate of Candidates for IES Section Governing Board 2014-2016 Term
View the Slate of Candidates for Emerging Companies Section Governing Board 2014-2015 Term
View the Slate of Candidates for Food and Agriculture Section Governing Board 2014-2017 Term
Slate of Candidates for IES Section Governing Board 2014-2016 Term
- Charles R. (Chas) Eggert, President & CEO, OPX Biotechnologies
- Mark Jones, Executive Strategy and Communications Director, Dow Chemical Company
- Adam Monroe, President, Novozymes North America, Novozymes
- Christopher Standlee, Executive Vice President for Institutional Relationships and Governmental Affairs, Abengoa Bioenergy US Holding, Inc.
- Stephan Tanda, Managing Board of Directors, DSM
- Marc Verbruggen, President & CEO, NatureWorks LLC
Slate of Candidates for Emerging Companies Section Governing Board 2014-2015 Term
- Martin Babler, President & CEO, Principa Biopharma
- Marc Beer, Chief Executive Officer, Aegerion Pharmaceuticals
- Alexis Borisy, Chairman, Foundation Medicine
- Ron Cohen, President & CEO, Acorda Therapeutics
- John Crowley, Chairman & CEO, Amicus Therapeutics
- Michelle Dipp, Chief Executive Officer, OvaScience
- Douglas Doerfler, President & CEO, MaxCyte
- Maxine Gowen, President & CEO, Trevena
- Peter Greenleaf, President & CEO, Sucampo
- Faheem Hasnain, President & CEO, Receptos
- Paul Hastings, President & CEO, OncoMed Pharmaceuticals
- Jeffrey Hatfield, President & CEO, Vitae Pharmaceuticals
- Russell Herndon, President & CEO, Hydra Biosciences
- Perry Karsen, Chief Operating Officer, Celgene Corporation
- Rachel King, Chief Executive Officer, GlycoMimetics
- Robert Kiss, Managing Director, J.P. Morgan Asset Management
- Scott Koenig, President & CEO, MacroGenics
- Emer Leahy, President & CEO, PsychoGenics
- Jonathan Leff, Partner, Deerfield
- Nick Leschly, President & CEO, bluebird bio
- John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals
- Thomas Mathers, Chief Executive Officer, CoLucid Pharmaceuticals
- John Mendlein, Executive Chairman & CEO, Atyr Pharma
- Steven Mento, President, CEO, Co-founder, Chairman, Conatus Pharmaceuticals
- Arlene Morris, Chief Executive Officer, Syndax Pharmaceuticals
- Mike Narachi, Chief Executive Officer, Orexigen
- John Orwin, Chief Executive Officer, Relypsa
- Stuart Peltz, President & CEO, PTC Therapeutics
- Adelene Perkins, President & CEO, Infinity Pharmaceuticals
- Kristine Peterson, Chief Executive Officer, Valeritas
- Mark Pruzanski, Founder, President, & CEO, Intercept Pharmaceuticals
- Timothy Rodell, President & CEO, GlobeImmune
- David Schenkein, Chief Executive Officer, Agios Pharmaceuticals
- Moncef Slaoui, Chairman of R&D, GlaxoSmithKline
- Gil Van Bokkelen, Chairman & CEO, Athersys
- Harold Van Wart, President & CEO, CymaBay Therapeutics
- Timothy Walbert, Chairman, President & CEO, Horizon Pharma
- Kleanthis Xanthopoulos, President & CEO, Regulus Therapeutics
- Bradford Zakes, Chief Executive Officer, Cerevast Therapeutics
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
- VACANT
Slate of Candidates for Food and Agriculture Section Governing Board 2014-2017 Term
- Jerry Flint, Vice President, Biotech Affairs and Regulatory, DuPont Pioneer
- Neal Gutterson, President & CEO, Mendel Biotechnology
- Matthias Meder, Vice President, Stewardship and Regulatory, BASF Plant Science
- Philip Miller, Vice President Global Regulatory and Government Affairs, Monsanto
- Daphne Preuss, President & CEO, Chromatin
- Rob Readnour, Senior Director of Product Development, Elanco Animal Health
- Brad Shurdut, Global Leader, Government and Regulatory Affairs, Dow AgroSciences
- Ron Stotish, President & CEO, Aqua Bounty Technologies
- Eddie Sullivan, Vice President of Business Development & Government Relations and Head of Sanford Applied Biosciences
- Frank Terhorst, Global Head of Seeds, Bayer CropScience
- Mark Wong, Chairman of the Board, Agrivida
- VACANT
- VACANT
- VACANT